Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families.

Biotechnology

Denali Therapeutics

Ryan Watts

Chris Koth

Mark Rowen

Michelle Polowski

Chris Walsh

Cynthia Wong

Katie Peng

Kirk Henne

Dana Andersen

Alex Schuth

Michael Ostland

Wei Dong

Fabian Model

Joe Lewcock

Cindy Dunkle

Carole Ho

The Board Members at Denali Therapeutics provide strategic oversight and governance, ensuring the company stays true to its mission of defeating neurodegenerative diseases. They guide executive decisions, oversee financial health, and uphold the highest ethical standards in scientific research and clinical development.

Board Members

Clinical and Development

Leadership Team

Board Members

About

Team members

Other teams at Denali Therapeutics

Clinical and Development

Leadership Team